ArticleMetabolism open2021

SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19.

Zemene Demelash Kifle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.